Insights from Peak Proteins about protein supply, structure determination, mass spectrometry, and biophysical characterisation.
View in browser
very latest new dark logo - Copy-1

Working collaboratively to provide creative solutions

to protein challenges in drug discovery

antibody

Making sense of Bio-Logics

This month we're focusing on one of our areas of specialisation - Biotherapeutic proteins.

At Peak Proteins (part of Sygnature Discovery) we have extensive experience supporting early-stage development of protein based biotherapeutic molecules.

The Role of Structural Biology in the Development of Biotherapeutics

We discuss the critical role structural biology plays in the design, engineering and application of therapeutic antibodies.

Read more

fab image

F2.large-1

Recent publication on the Development of New Anti-Thrombotic Biotherapeutics

Two Peak Proteins/Sygnature scientists, Juli Warwicker and Mark Abbott, have recently co-authored a paper on a new family of anti-thrombotic therapeutics.

Read more

 

New Biotherapeutics Web Page

To highlight our Biotherapeutic and custom antibody capabilities we have recently added a dedicated page on our website

Take a look !

new page

More Biotherapeutic Protein content

Enhancing Biotherapeutic Protein yield through CHO Expression Optimisation

More Papain, More Problems

Using Design of Experiments to Increase Protein Yield in HEK293 6E cells

Time critical purification of multiple Fab constructs for assay

How Was the Structure of G6b-B Determined?

Slide1

Protein Expression and Protein Purification

Find Out More
Slide2

Protein Structure Determination

Find Out More
Slide3
Protein
Characterisation
Find Out More

readmore2
my signature banner thing
LinkedIn
X

Sygnature Discovery, BioCity, Pennyfoot Street, Nottingham, Nottinghamshire NG1 1GR, United Kingdom, +44 (0)115 941 5401

Unsubscribe Manage preferences